Clinical Trials Browser

Glioma × mirdametinib × 1 year × Clear all

NCT07539441 2026-05-13

A Study of Mirdametinib in People With Central Nervous System Tumors

Phase 1/2 Recruiting

Glioma, Central Nervous System Neoplasms

NCT07521657 2026-04-13

NF118

Phase 2 Not yet recruiting

Glioblastoma, Glioma, Neurofibromatosis 1